MedLink Global Launched AI Psychiatry Tool

The new Comentra platform aims to assist clinicians with diagnosis and evidence-based treatment plans.

Updated on Oct. 4, 2026 in Mental Health

Isometric editorial illustration of a clean, geometric clinical office featuring a central abstract pillar, representing modern medical data synthesis.
MedLink Global has launched Comentra, an AI-powered clinical decision support platform designed to assist psychiatrists with patient data and evidence-based treatment. AI Illustration. Upload story photo >

Live Poll

Do you trust artificial intelligence to help your doctor decide on your mental health treatment?

MedLink Global has developed an AI-based clinical decision support platform called Comentra to assist psychiatrists. The system uses patient history and ambient speech to offer treatment options.

Why it matters

The platform seeks to provide clinicians with a comprehensive view of patient data and evidence-based recommendations. It is designed to bridge information gaps during psychiatric evaluations.

A 2025 review identified 84 AI-enabled mental health tools, yet only 7 hold regulatory clearance. Among these, there are only 5 peer-reviewed validation studies available.

The players

MedLink Global

MedLink Global is the company that developed the AI-based Comentra psychiatric support platform.

Christoph Correll

Christoph Correll serves as the chief medical officer at MedLink Global.

The details

Comentra integrates patient history and ambient speech to help clinicians update diagnosis and treatment plans. The system is programmed to generate questions to fill information gaps and is restricted from offering recommendations when data is insufficient.

Timeline

  1. A review of AI-enabled mental health tools was conducted in 2025.

  2. The MedLink Global website was accessed on October 3, 2026.

  3. This information was published on October 4, 2026.

The Big Picture

The development of Comentra follows a pattern established by the 2025 review, which underscored the scarcity of regulatory-cleared tools in the mental health AI space.

The platform is designed to assist psychiatrists in generating more comprehensive treatment plans for their patients. Patients may experience improved diagnostic accuracy as clinicians utilize these AI-driven decision support tools.

The takeaway

Clinicians must balance the potential benefits of AI assistance with the current lack of widespread peer-reviewed validation for such tools. Users should ensure any AI tool used in practice adheres to existing regulatory standards.

Further reading

For more information on current developments in the field, explore the Mental Health section.

More information

To learn more about the platform technology and company background, visit the MedLink Global company information.

Live Poll

Do you trust artificial intelligence to help your doctor decide on your mental health treatment?